Avalanche & Regeneron join forces to develop next generation gene therapy products for the eye
Two US companies, Regeneron Pharmaceuticals Inc., (NASDAQ: REGN) and Avalanche Biotechnologies, Inc announced the formation of a new collaboration to “discover, develop and commercialize novel… Read More »Avalanche & Regeneron join forces to develop next generation gene therapy products for the eye